Interpace Biosciences, Inc.
IDXG
$1.14
-$0.03-2.56%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 2.89M | 1.28M | 2.06M | 468.00K | 2.04M |
| Total Depreciation and Amortization | 211.00K | 189.00K | 188.00K | 160.00K | 186.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | 0.00 |
| Total Other Non-Cash Items | 249.00K | 494.00K | 7.00K | 122.00K | 434.00K |
| Change in Net Operating Assets | -2.17M | 153.00K | -853.00K | -808.00K | -1.52M |
| Cash from Operations | 1.18M | 2.12M | 1.40M | -58.00K | 1.14M |
| Capital Expenditure | -129.00K | -522.00K | -197.00K | -28.00K | -142.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Investing | -129.00K | -522.00K | -197.00K | -28.00K | -142.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.50M | -1.50M | -2.00M | -600.00K | 0.00 |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -46.00K | -- | -- | -- | -32.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -161.00K | -- | -- | -- | -2.50M |
| Cash from Financing | -1.71M | -1.50M | -2.00M | -600.00K | -2.53M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -652.00K | 94.00K | -793.00K | -686.00K | -1.53M |